España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Acumen Pharmaceuticals
ABOS
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$2.31
-0.06
-2.53%
At close: -
$2.31
0
0.00%
After Hours: 4:02 PM EDT
Get Report
Comment
Acumen Pharmaceuticals (ABOS) Forecast
News
Earnings
Acumen Pharmaceuticals (ABOS) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Acumen Pharmaceuticals (NASDAQ:ABOS) Stock
Acumen Pharmaceuticals Stock (NASDAQ: ABOS)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, November 13, 2024
HC Wainwright & Co. Reiterates Buy on Acumen ...
Benzinga Newsdesk
Tuesday, November 12, 2024
Acumen Pharmaceuticals Q3 2024 GAAP EPS $(0.5...
Benzinga Newsdesk
Earnings Scheduled For November 12, 2024
Benzinga Insights
Monday, November 11, 2024
Acumen Pharmaceuticals Earnings Preview
Benzinga Insights
Thursday, October 31, 2024
Acumen Pharmaceuticals Presented Encouraging ...
Benzinga Newsdesk
Wednesday, October 23, 2024
Acumen Pharmaceuticals To Deliver Late-Breaki...
Benzinga Newsdesk
Thursday, October 03, 2024
HC Wainwright & Co. Reiterates Buy on Acumen ...
Benzinga Newsdesk
Thursday, September 26, 2024
Acumen Pharmaceuticals Extends Collaboration ...
Benzinga Newsdesk
Thursday, August 15, 2024
UBS Maintains Buy on Acumen Pharmaceuticals, ...
Benzinga Newsdesk
Wednesday, August 14, 2024
Acumen Pharmaceuticals shares are trading low...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on Acumen ...
Benzinga Newsdesk
Tuesday, August 13, 2024
Acumen Pharmaceuticals Q2 2024 GAAP EPS $(0.3...
Benzinga Newsdesk
Monday, July 29, 2024
Acumen Pharmaceuticals Has Dosed The First Su...
Benzinga Newsdesk
Sunday, July 28, 2024
Acumen Reported Phase 1 Results for Sabirnetu...
Benzinga Newsdesk
Thursday, July 25, 2024
Citigroup Initiates Coverage On Acumen Pharma...
Benzinga Newsdesk
Thursday, July 11, 2024
Acumen Pharmaceuticals To Present Patient Exp...
Benzinga Newsdesk
Thursday, June 06, 2024
Halozyme's ENHANZE Product Gets New Patent Grant in EU
Zacks
Wednesday, May 15, 2024
HC Wainwright & Co. Reiterates Buy on Acumen ...
Benzinga Newsdesk
Tuesday, May 14, 2024
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights
Acumen Pharmaceuticals Q1 2024 GAAP EPS $(0.2...
Benzinga Newsdesk
Wednesday, May 08, 2024
Acumen Pharmaceuticals Says First Patient Dos...
Benzinga Newsdesk
Thursday, April 18, 2024
Watching Eledon Pharmaceuticals, Acumen Pharm...
Benzinga Newsdesk
Tuesday, April 16, 2024
Acumen Pharmaceuticals Presents First Compreh...
Benzinga Newsdesk
Thursday, April 04, 2024
Acumen Pharmaceuticals Collaborates With Lonz...
Benzinga Newsdesk
Wednesday, March 27, 2024
HC Wainwright & Co. Maintains Buy on Acumen P...
Benzinga Newsdesk
Tuesday, March 26, 2024
Acumen Pharmaceuticals shares are trading low...
Benzinga Newsdesk
Acumen Pharmaceuticals Q4 EPS $(0.29) Misses $(0.26) Estimate
Happy Mohamed
Acumen Pharmaceuticals FY23 EPS $(1.08) Down ...
Benzinga Newsdesk
Earnings Scheduled For March 26, 2024
Benzinga Insights
Monday, March 25, 2024
Acumen Pharmaceuticals's Earnings: A Preview
Benzinga Insights
Thursday, March 21, 2024
Acumen Pharmaceuticals To Present Deeper Insi...
Benzinga Newsdesk
Friday, March 08, 2024
Acumen Pharmaceuticals Presents Sabirnetug Fl...
Benzinga Newsdesk
Acumen Pharmaceuticals shares are trading hig...
Benzinga Newsdesk
Wednesday, February 21, 2024
Acumen Pharmaceuticals To Present Sabirnetug ...
Benzinga Newsdesk
Thursday, February 01, 2024
Acumen Pharmaceuticals Appointsf James Dohert...
Benzinga Newsdesk
Tuesday, December 12, 2023
Deutsche Bank Initiates Coverage On Acumen Ph...
Benzinga Newsdesk
Monday, November 13, 2023
Acumen Pharmaceuticals Secures $50.0M Credit ...
Benzinga Newsdesk
Acumen Pharmaceuticals Q3 EPS $(0.24) Vs $(0....
Benzinga Newsdesk
Earnings Scheduled For November 13, 2023
Benzinga Insights
Friday, November 10, 2023
Acumen Pharmaceuticals's Earnings Outlook
Benzinga Insights
Monday, November 06, 2023
Acumen Pharmaceuticals, Inc. And Halozyme Ent...
Benzinga Newsdesk
Friday, October 27, 2023
Acumen Pharmaceuticals Presents Late-Breaker ...
Benzinga Newsdesk
Wednesday, October 04, 2023
Acumen Pharmaceuticals To Present Deeper Insi...
Benzinga Newsdesk
Wednesday, September 06, 2023
Upcoming Phase 2 Data Expected For Longeveron's (NASDAQ: LGVN) Drug For the $4+ Billion Alzheimer's Sector – What To Look For
David Willey
-
Sponsored
Wednesday, August 09, 2023
Credit Suisse Reiterates Outperform on Acumen...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on Acumen ...
Benzinga Newsdesk
Tuesday, August 08, 2023
Acumen Pharmaceuticals Q2 EPS $(0.28) Beats $...
Benzinga Newsdesk
Earnings Scheduled For August 8, 2023
Benzinga Insights
Monday, August 07, 2023
Acumen Pharmaceuticals's Earnings: A Preview
Benzinga Insights
Wednesday, July 26, 2023
Director At This Health Care Company Buys $40.00M of Stock
Benzinga Insights
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch